SynthesisFrontiers in psychiatry2025
Non-verbal behaviours as predictors for treatment response in patients with depression or schizophrenia: a systematic review.
Synthesis in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eye-Tracking Phenotypes Across the Depressive Spectrum: Joint Modeling of Diagnostic Group and Symptom Severity.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Non-verbal behaviours (NVBs) reveal information about mood and emotions, potentially providing an objective means to measure and monitor early treatment responses. Previous research has examined NVB changes during treatment in patients with depression and psychosis but a systematic evaluation of the evidence is lacking. Furthermore, this review could inform the fast moving field of digital and precision psychiatry due to the use of AI-based technology that could transform the potential of NVBs as reliable biomarkers for treatment response. Methods: Medline, Embase, PsycINFO and CINAHL were searched in June 2024. Included papers studied adults diagnosed with depression or schizophrenia and measured NVBs at least twice during separate clinical interviews. Outcomes of interest were changes in clinical symptoms and NVBs following treatment initiation. Treatment strategies included hospitalisation, pharmacological, psychological, neuromodulatory, other non-standardised interventions, or a combination of approaches. Two reviewers independently extracted data and assessed risk of bias. The protocol for the review was registered on PROSPERO. Results: 20 papers were identified; 15 on depression, two on schizophrenia and three evaluating both conditions separately. Methodological variations across studies made comparisons challenging. NVBs consistently associated with improvement in depression symptoms included: increased smiling, facial expressivity, and amplified head and body movements. Results across studies were more consistent when considering general categories of behaviour, versus discrete facial behaviours. No commonalities were observed in NVB changes over time for patients with schizophrenia. Discussion: The existing evidence is presently insufficient to establish distinct behavioural profiles for clinical improvement depression or schizophrenia. Despite implicit challenges, there is considerable future scope in the evaluation of NVBs as predictors of clinical outcomes or change. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42022368599.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.